Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Online resources offer a wealth of information for investment research. Learn how to leverage these tools to improve your investment approach.
21,367 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
The Massachusetts Supreme Judicial Court unanimously blocked a statewide rent stabilization petition from the 2026 ba...
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
A high pre-tax withdrawal can push Social Security into higher taxation, prolonging Medicare costs and altering retir...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
The crypto market today, june is marked by a broad selloff across major tokens as inflation concerns rise and risk ap...
Ten major tech names linked to AI have fallen into bear territory, signaling a sharp repricing as earnings discipline...
Tech stocks just their footing as an AI spending surge loses steam. The sector faced a rough week, driven by slower d...
As the nation marks its 250th birthday, Anthony Scaramucci urges a return to thrift and steady investing to protect h...
When headlines shout about who a beloved celebrity is dating, it’s easy to miss the money lessons behind the gossip. ...
A dividend-focused ETF beats a broad market gain on yield and stability. Invesco’s SPHD offers 4.57% income with lowe...